Who
Juliana Papa Drinane
Head of Mfg & Supply
Company insider
Files Form 4 as: Head of Mfg & Supply, Organon & Co.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $401K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Nov 2025
- Last trade
- 5 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 5 Aug 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Sold | $200K14,761 at $13.57 | filing |
| 5 Aug 2026filed 5 Aug 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Sold | $200K14,761 at $13.57 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code M | —6,378 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code F | $12K2,185 at $5.70 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code M | —10,073 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —125,208 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,378 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —10,073 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code F | $20K3,451 at $5.70 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —125,208 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,378 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —10,073 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code M | —6,378 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code F | $12K2,185 at $5.70 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code M | —10,073 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code F | $20K3,451 at $5.70 | filing |
| 29 Mar 2026filed 31 Mar 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code M | —7,979 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | OGN Organon & CoPharmaceuticals | SEC FORM 4 Code F | $16K2,733 at $5.84 | filing |
| 29 Mar 2026filed 31 Mar 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,979 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,979 at $0.00 | filing |
News
Critical Contrast: Organon & Co. (NYSE:OGN) & Xeris Biopharma (NASDAQ:XERS)OGN · tickerreport.com · 21 Oct 2026Head-To-Head Survey: Organon & Co. (NYSE:OGN) versus Xeris Biopharma (NASDAQ:XERS)OGN · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Juliana Papa Drinane; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.